Document is current
Any future updates will be listed below
-
Authors
Simuni, Tanya https://orcid.org/0000-0002-2347-1644
Merchant, Kalpana
Brumm, Michael C.
Cho, Hyunkeun
Caspell-Garcia, Chelsea
Coffey, Christopher S.
Chahine, Lana M.
Alcalay, Roy N.
Nudelman, Kelly https://orcid.org/0000-0003-4040-1717
Foroud, Tatiana
Mollenhauer, Brit
Siderowf, Andrew
Tanner, Caroline https://orcid.org/0000-0002-3775-5082
Iwaki, Hirotaka
Sherer, Todd
Marek, Kenneth
,
,
Siderowf, Andrew
Seibyl, John
Coffey, Christopher
Tosun-Turgut, Duygu
Shaw, Leslie M.
Trojanowski, John Q.
Singleton, Andrew
Kieburtz, Karl
Toga, Arthur
Mollenhauer, Brit
Galasko, Douglas
Poewe, Werner
Foroud, Tatiana
Poston, Kathleen
Bressman, Susan
Reimer, Alyssa
Arnedo, Vanessa
Clark, Adrienne
Frasier, Mark
Kopil, Catherine
Chowdhury, Sohini
,
Casaceli, Cynthia
Dorsey, Ray
Wilson, Renee
Mahes, Sugi
Seibyl, John
Salerno, Christina
Ahrens, Monica
Brumm, Michael
Cho, Hyunkeun Ryan
Fedler, Janel
LaFontant, David-Erick
Kurth, Ryan
Crawford, Karen
Casalin, Paola
Malferrari, Giulia
Weisz, Mali Gani
Orr-Urtreger, Avi
Trojanowski, John
Shaw, Leslie
Montine, Thomas
Baglieri, Chris
Christini, Amanda
,
Russell, David
Dahodwala, Nabila
Giladi, Nir
Factor, Stewart
Hogarth, Penelope
Standaert, David
Hauser, Robert
Jankovic, Joseph
Saint-Hilaire, Marie
Richard, Irene
Shprecher, David
Fernandez, Hubert
Brockmann, Katrina
Rosenthal, Liana
Barone, Paolo
Espayc, Alberto
Rowe, Dominic
Marder, Karen
Santiago, Anthony
Bressman, Susan
Hu, Shu-Ching
Isaacson, Stuart
Corvol, Jean-Christophe
Martinez, Javiar Ruiz
Tolosa, Eduardo
Tai, Yen
Politis, Marios
,
Smejdir, Debra
Rees, Linda
Williams, Karen
Kausar, Farah
Williams, Karen
Richardson, Whitney
Willeke, Diana
Peacock, Shawnees
Sommerfeld, Barbara
Freed, Alison
Wakeman, Katrina
Blair, Courtney
Guthrie, Stephanie
Harrell, Leigh
Hunter, Christine
Thomas, Cathi-Ann
James, Raymond
Zimmerman, Grace
Brown, Victoria
Mule, Jennifer
Hilt, Ella
Ribb, Kori
Ainscough, Susan
Wethington, Misty
Ranola, Madelaine
Santana, Helen Mejia
Moreno, Juliana
Raymond, Deborah
Speketer, Krista
Carvajal, Lisbeth
Carvalo, Stephanie
Croitoru, Ioana
Garrido, Alicia
Payne, Laura Marie
,
Viswanth, Veena
Severt, Lawrence
Facheris, Maurizio
Soares, Holly
Mintun, Mark A.
Cedarbaum, Jesse
Taylor, Peggy
Biglan, Kevin
Vandenbroucke, Emily
Sheikh, Zulfiqar Haider
Bingol, Baris
Fischer, Tanya
Sardi, Pablo
Forrat, Remi
Reith, Alastair
Egebjerg, Jan
Hillert, Gabrielle Ahlberg
Saba, Barbara
Min, Chris
Umek, Robert
Mather, Joe
De Santi, Susan
Post, Anke
Boess, Frank
Taylor, Kirsten
Grachev, Igor
Avbersek, Andreja
Muglia, Pierandrea
Merchant, Kaplana
Tauscher, Johannes
- License Information
-
More Information
Article History
Received: 2 June 2022
Accepted: 29 September 2022
First Online: 22 October 2022
Competing interests
: Tanya Simuni, MD has served as a consultant for 4D Pharma, Acadia, AcureX, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson’s Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Sunovion, Roche, Takeda, UCB, Vanqua Bio and Voyager. Dr. Simuni served on the ad board for Acadia, AcureX, AskBio, Amneal, Denali, Sunovion, Roche. Dr. Simuni has served as a member of the scientific advisory board of 4D Pharma, Neuroderm, Sanofi and UCB. Dr. Simuni has received research funding from Amneal, Biogen, Roche, Neuroderm, Sanofi, Prevail and UCB and an investigator for NINDS, MJFF, Parkinson’s Foundation. Michael C. Brumm, MS reports no disclosures. Hyunkeun Ryan Cho, PhD reports no disclosures. Chelsea Caspell-Garcia, MS reports no disclosures. Christopher S. Coffey, PhD receives funding from NINDS, NHLBI, and the Michael J. Fox Foundation. He is also a paid consultant to MJFF. Andrew Siderowf, MD has been a consultant to the following companies in the past year: Biogen, Merck, Denali, Wave Life Sciences and Prilenia Therapeutics. He has received grant funding from the Michael J. Fox Foundation and NINDS. Tatiana Foroud, PhD receives funding from the National Institutes of Health (NIH), The Michael J. Fox Foundation, the US Department of Defense. Kelly Nudelman, PhD receives funding from the National Institutes of Health (NIH), the Michael J. Fox Foundation, the National Collegiate Athletic Association, the United States Department of Defense, the United States Army Medical Research Acquisition Activity, the National Alzheimer’s Coordinating Center, the Indiana State Department of Health, the Lilly Endowment Incorporated, and Biohaven Pharmaceuticals, Inc. Brit Mollenhauer, MD is employed by Parcacelsus Kliniken Germany and the University medical center Goettingen; BM has received independent research grants from TEVA-Pharma, Desitin, Boehringer Ingelheim, GE Healthcare and honoraria for consultancy from Bayer Schering Pharma AG, Roche, AbbVie, TEVA-Pharma, Biogen and for presentations from GlaxoSmithKline, Orion Pharma, TEVA-Pharma and travel costs from TEVA-Pharma. BM is member of the executive steering committee of the Parkinson Progression Marker Initiative and the Systemic Synuclein Sampling Study of the Michael J. Fox Foundation for Parkinson’s Research and has received grants from the BMBF, EU, Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung, Michael J. Fox Foundation for Parkinson’s Research, Stifterverband für die deutsche Wissenschaft, and has scientific collaborations with Roche, Bristol Myers Squibb, Ely Lilly, Covance and Biogen. Caroline M. Tanner, MD, PhD is an employee of the San Francisco Veterans Affairs Medical Center and the University of California – San Francisco. She receives grants from the Michael J. Fox Foundation, the Parkinson’s Foundation, the Department of Defense, BioElectron, Roche/Genentech, Biogen Idec and the National Institutes of Health, compensation for serving on Data Monitoring Committees from Biotie Therapeutics, Voyager Therapeutics and Intec Pharma and personal fees for consulting from Neurocrine Biosciences, Adamas Therapeutics, Biogen Idec, 23andMe, Alexza, Grey Matter and CNS Ratings. Lana M. Chahine, MD receives research support from the Michael J. Fox Foundation, UPMC Competitive Medical Research Fund, and the University of Pittsburgh, support as site investigator for a study sponsored by Biogen, receives research support from the National Institutes of Health, receives consulting fees from Grey Matter Technologies, receives royalties from Elsevier (for authorship), and receives royalties from Wolters Kluwel (for authorship). Roy Alcalay, MD MS, receives research support from the NIH, DoD, Parkinson’s Foundation, MJFF. He received consultation fees from Avrobio, Caraway, Merck, GSK, Ono Therapeutics, Sanofi and Takeda. Hirotaka Iwaki, MD, PhD is a consultant employed by Data Tecnica International, whose participation in this is part of a consulting agreement between the US National Institutes of Health and said company. Todd Sherer, PhD is employed by The Michael J. Fox Foundation. Kenneth Marek is a consultant for MJFox Foundation, GE Healthcare, Biogen, Prothena, Roche, Neuropore, US Worldmeds, Proclara, Oxford Biomedica, Prevail, UCB, Neuraly, Lysosomal Therapetic, Inc, Neuroderm, Denali, Takeda W81XWH-06-1-0678 Establishing an ‘at risk’ cohort for Parkinson Disease Neuroprevention using olfactory testing and DAT imaging, DOD, Investigator 10/1/06–09/30/19; Parkinson Progression Marker Initiative (PPMI), Michael J. Fox Foundation, Principal Investigator; DAT imaging in LRRK2 family members, the Michael J. Fox Foundation, Principal Investigator 1/15/10–1/14/23. Ownership in Invicro, LLC.
